Cetera Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Cetera Advisors's RGEN Position: Q2 2023 in Review
Cetera Advisors sold out of Repligen (RGEN) in Q2 2023, closing a stake of 1,435 shares — an estimated $242K sold.
Cetera Advisors first reported a position in RGEN in Q2 2019 and held it in 16 quarters. The position peaked at $613K in Q3 2021. 446 funds tracked by Wall St. Rank hold RGEN as of Q2 2023.
- Cetera Advisors reported no remaining Repligen position as of Q2 2023 after selling out during the quarter.
- Cetera Advisors sold 1,435 Repligen shares in Q2 2023, an estimated $242K.
- Cetera Advisors first reported a position in Repligen in Q2 2019 and held it in 16 quarters.
- Cetera Advisors's Repligen position peaked at $613K in Q3 2021.
- 446 funds tracked by Wall St. Rank held Repligen as of Q2 2023.
Based on Cetera Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.